Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 9Desmoid Tumors 4Triple Negative Breast Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1Leukemia 1Granulosa cell tumor of the ovary 1Breast Cancer Metastatic 1Advanced Solid Tumors 1

Interventions

Trastuzumab 3Docetaxel 3Gemcitabine 2tusamitamab ravtansine 1nirogacestat 1margetuximab 1exemestane 1Vinorelbine 1Tamoxifen 1Letrozole 1Fulvestrant 1Capecitabine 1Anastrozole 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Breast Cancer Metastatic × nirogacestat × Clear all
NCT01876251 2019-03-15

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Pfizer

Phase 1 Terminated
30 enrolled 29 charts
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡